share_log

Anika Therapeutics | PRER14A: Preliminary revised proxy soliciting materials

SEC ·  Apr 25, 2023 16:56
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more